Andrew Simpson Buys Shares of HSCS $HSCS

Key Points

  • Andrew Simpson bought 425,000 shares of HeartSciences Inc. ($HSCS).
  • $HSCS last traded around $2.63.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Andrew Simpson, Chairman of the Board, President and Chief Executive Officer at HeartSciences Inc. ($HSCS), bought 425,000 shares. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

HeartSciences Inc. Stock Down 13.2%

Shares of HeartSciences Inc. ($HSCS) traded around $2.63 on Thursday, down 13.2% for the day.

Last price$2.63
Market cap$14.19M
Forward P/E-1.69
Beta1.80
52-week low$1.63
52-week high$3.80
50-day MA$2.51
200-day MA$2.52
Current ratio0.53
Quick ratio0.34
Debt-to-equity17.41

HeartSciences Inc. Earnings

EPS (ttm)-$3.64
Revenue (ttm)$4.32K
Revenue growth-100%
Net margin0%
Return on equity-4239.91%

Analysts Set New Price Targets

Average target$10
High target$12
Low target$8
Analysts covering2

About HeartSciences Inc.

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

ExchangeNasdaqCM
SectorHealthcare
IndustryMedical Devices
HeadquartersSouthlake, TX
CEOMr. Andrew Simpson
Employees14

Get HeartSciences Inc. alerts

New 13F filings, insider trades, and analyst moves on $HSCS, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.